Story thread · 3 reports / 3 sources
Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
thestar.com · 1h · first report
How the coverage leans
Across 3 sources · syndicated copies counted once
WARMINSTER, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced plans to commence a modified “Dutch Auction” tender offer (the “Offer”) to repurchase…
The coverage
- Arbutus to repurchase up to $230M of shares in tender offer
seekingalpha.com · 1h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.